DEA judge sets timeline for rescheduling hearings | Where to buy Skittles Moonrock online

Learn where to buy marijuana online. TOP QUALITY GRADE A++

Cannabyss Inc. is the best place online to buy top quality weed, cannabis, vape, marijuana and CBD products. Get your borderless orders delivered at the pickup spot with ease. Top Grade products for client satisfaction.

👉 Click here to Visit our shop! 🛒

Federal hearings to peg cannabis down the drug scheduling ladder begin Jan. 21 and will run six weeks, a Drug Enforcement Administration judge ruled Wednesday.

Chief Administrative Law Judge John Mulrooney II laid out a detailed schedule for testimony from both supporters and opponents of moving marijuana from Schedule I to the less-restrictive Schedule III drug classification.

“The time has come to receive evidence and proceed with the hearing,” Mulrooney wrote, closing the preliminary motion period.

The DEA, which earlier this week claimed its role as the proposal’s proponent, will testify first at the agency’s Virginia headquarters. Each party will have 90 minutes to present evidence plus opening and closing statements. Hearings will run 9:30 a.m. to 5 p.m. ET Tuesday through Thursday each week.

Pro-rescheduling groups like the National Cannabis Industry Association will testify through Feb. 6. After a week’s break, opponents including Smart Approaches to Marijuana (SAM) will present their case from Feb. 18 to March 6.

Mulrooney in a footnote also determined that over 43,000 public comments submitted on rescheduling “cannot be” considered as evidence in the formal proceedings. He recently rejected motions to disqualify DEA from the process over alleged bias and communications with anti-cannabis groups.

If marijuana moves to Schedule III, state-licensed cannabis businesses could gain tax benefits while some research restrictions would ease, though federal controls would remain in place.

All parties must submit documentation by January 3. Cross-examination will be limited to 20 minutes per opposing party.

Recent motions to pause proceedings until after President-elect Donald Trump takes office have been unsuccessful.

Pro-rescheduling testimony (Jan. 21-Feb. 6):

• Jan. 21: DEA (as proponent)
• Jan. 22: Hemp for Victory
• Jan. 23: Cannabis Bioscience International
• Jan. 28: Connecticut Cannabis Ombudsman group
• Jan. 29: National Cannabis Industry Association
• Jan. 30: Village Farms International
• Feb. 4: The Commonwealth Project
• Feb. 5: Veterans Initiative 22
• Feb. 6: Dr. Ari Kirshenbaum

After a week break, anti-rescheduling testimony (Feb. 18-March 6):

• Feb. 18: Tennessee Bureau of Investigation
• Feb. 19: International Association of Chiefs of Police
• Feb. 20: DEA Federal Narcotics Agents Association
• Feb. 25: Smart Approaches to Marijuana/Nebraska
• Feb. 26: Community Anti-Drug Coalitions of America
• Feb. 27: Cannabis Industry Victims Educating Litigators
• March 4: Dr. Kenneth Finn
• March 5: National Drug and Alcohol Screening Association
• March 6: Dr. Phillip Drum

reschedulingruling1204